Recently, according to the notice issued by the National Joint Procurement Office for High-Value Medical Consumables, Beijing Huakang Tianyi Biotechnology Co., Ltd. (hereinafter referred to as "Huakang Tianyi") successfully applied for adding products and obtained the qualification for selection in the continued procurement after the expiration of the centralized volume procurement agreement for artificial joints. The company applied to accept the selected price for the same product sy
Recently, according to a notice issued by the National Joint Procurement Office for High-Value Medical Consumables, Beijing Huakang Tianyi Biotech Co., Ltd. (hereinafter referred to as "Huakang Tianyi") successfully applied for supplementary products and obtained the bid-winning qualification in the follow-up procurement after the expiration of the centralized volume-based procurement agreement for artificial joints.
The company applied to accept the bid-winning price of the same product system category of the enterprise, which complies with the requirements of the procurement documents, and the relevant products can be implemented as bid-winning product systems. This bid-winning marks that Huakang Tianyi's product quality and cost control capabilities in the field of orthopedic implants have been recognized at the national centralized procurement level, laying a solid foundation for the company to further expand the domestic market and improve product accessibility.
